Illustration: Gabriella Turrisi/Axios
Convoke, an AI software tool for biopharma companies, raised $8.6 million in a seed round, CEO Alex Telford tells Axios Pro exclusively.
Why it matters: It joins a growing group of AI startups betting on pharma's need to cut drug development timelines and costs.
